Abstract
Purpose of Review
To present the available literature pertaining to the management of lower urinary tract symptoms (LUTS) after pelvic radiation (RT) in female patients treated for pelvic malignancy.
Recent Findings
Recent publications have focused on isolating de novo RT-induced LUTS in women from other contributors to urinary symptoms such as pelvic surgery and chemotherapy. There is a paucity of literature on the treatment of RT-related changes to urinary function.
Summary
The treatment of pelvic malignancies in women alters voiding function. RT contributes to the deterioration of voiding function. More study is needed to evaluate the efficacy of available therapies.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Zwaans BMM, Lamb LE, Bartolone S, Nicolai HE, Chancellor MB, Klaudia SW. Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. Int Urol Nephrol. 2018;50:1745–51.
Oh JK, Choo MS, Lee J, Park NH, Oh SJ. Short-term effect of radical hysterectomy with or without adjuvant radiation therapy on urodynamic parameters in patients with uterine cervical cancer. Int Neurourol J. 2012;16:91–5.
Katepratoom C, Manchana T, Amornwichet N. Lower urinary tract dysfunction and quality of life in cervical cancer survivors after concurrent chemoradiation versus radical hysterectomy. Int Urogynecol J. 2014;25:91–6.
Bregendahl S, Emmertsen KJ, Lindegaard JC, Laurberg S. Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study. Color Dis. 2015;17:26–37.
Kwaan MR, Fan Y, Jarosek S, Elliott SP. Long-term risk of urinary adverse events in curatively treated patients with rectal cancer: a population-based analysis. Dis Colon Rectum. 2017;60:682–90.
Hazewinkel MH, Sprangers MA, van der Velden J, et al. Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study. Gynecol Oncol. 2010;117:281–6.
Oda Y, Todo Y, Hanley S, Hosaka M, Takeda M, Watari H, et al. Risk factors for persistent low bladder compliance after radical hysterectomy. Int J Gynecol Cancer. 2011;21:167–72.
Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, et al. Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203. J Clin Oncol. 2018;36:2538–44.
Zullo MA, Manci N, Angioli R, Muzii L, Panici PB. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003;48:287–93.
Chen GD, Lin LY, Wang PH, Lee HS. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol. 2002;85:292–7.
Emirdar V, Nayki U, Ertas IE, Nayki C, Kulhan M, Yildirim Y. Urodynamic assessment of short-term effects of pelvic radiotherapy on bladder function in patients with gynecologic cancers. Ginekol Pol. 2016;87:552–8.
Chan TY, Epstein JI. Radiation or chemotherapy cystitis with “pseudocarcinomatous” features. Am J Surg Pathol. 2004;28:909–13.
• de Boer SM, Nout RA, Jurgenliemk-Schulz IM, et al. Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial. Int J Radiat Oncol Biol Phys. 2015;93:797 A large trial of women randomized to EBRT or VBT for stage I high risk EC with long term follow up of urinary quality of life.
•• Gormley, E. A., Lightner, D. J., Faraday, M. et al.: Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. The most compreshensive guidelines regarding overactive bladder evaluation and management.
Coyne KS, Thompson CL, Lai JS, Sexton CC. An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn. 2015;34:255–63.
•• Davis, R., Jones, J. S., Barocas, D. A. et al.: Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol, 188: 2473, 2012. The AUA guidelines regarding the evaluation of asymptomatic microscopic hematuria.
Bryant CM, Dowell CJ, Fairbrother G. Caffeine reduction education to improve urinary symptoms. Br J Nurs. 2002;11:560–5.
Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int. 2008;102:62–6.
Shamliyan T, Wyman J, Kane R L. Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness. Rockville (MD), 2012.
Yang EJ, Lim JY, Rah UW, Kim YB. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecol Oncol. 2012;125:705–11.
Jaszczynski J, Kojs Z, Stelmach A, et al. Post-irradiation bladder syndrome after radiotherapy of malignant neoplasm of small pelvis organs: an observational, non-interventional clinical study assessing VESIcare(R)/Solifenacin treatment results. Med Sci Monit. 2016;22:2691–8.
Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB. Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats. Eur Urol. 2009;56:159–67.
Okadome M, Saito T, Kitade S, Ariyoshi K, Shimamoto K, Kawano H, et al. Renal function and urological complications after radical hysterectomy with postoperative radiotherapy and platinum-based chemotherapy for cervical cancer. Jpn J Clin Oncol. 2018;48:115–23.
Banerji JS, Devasia A, Kekre NS, Chacko N. Early urinary diversion with ileal conduit and vesicovaginostomy in the treatment of radiation cystitis due to carcinoma cervix: a study from a tertiary care hospital in South India. ANZ J Surg. 2015;85:770–3.
Raup VT, Eswara JR, Weese JR, Potretzke AM, Brandes SB. Urinary-cutaneous fistulae in patients with neurogenic bladder. Urology. 2015;86:1222–7.
Smith AL, Ferlise VJ, Rovner ES. Female urethral strictures: successful management with long-term clean intermittent catheterization after urethral dilatation. BJU Int. 2006;98:96–9.
Goel A, Paul S, Dalela D, Sankhwar P, Sankhwar SN, Singh V. Dorsal onlay buccal mucosal graft urethroplasty in female urethral stricture disease: a single-center experience. Int Urogynecol J. 2014;25:525–30.
Kowalik C, Stoffel JT, Zinman L, Vanni AJ, Buckley JC. Intermediate outcomes after female urethral reconstruction: graft vs flap. Urology. 2014;83:1181–5.
Onol FF, Onol SY, Tahra A, et al. Ventral inlay labia minora graft urethroplasty for the management of female urethral strictures. Urology. 2014;83:460–4.
Singh M, Kapoor R, Kapoor D, et al. Dorsal onlay vaginal graft urethroplasty for female urethral stricture. Indian J Urol. 2013;29:124.
Suriano F, Altobelli E, Sergi F, et al. Bladder cancer after radiotherapy for prostate cancer. Rev Urol. 2013;15:108.
Shirodkar SP, Kishore TA, Soloway MS. The risk and prophylactic management of bladder cancer after various forms of radiotherapy. Curr Opin Urol. 2009;19:500–3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Laura S. Leddy reports personal fees from Boston Scientific and Ferring Pharmaceuticals.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction
Rights and permissions
About this article
Cite this article
Leddy, L.S. Management of Lower Urinary Tract Symptoms After Pelvic Radiation in Females. Curr Urol Rep 19, 106 (2018). https://doi.org/10.1007/s11934-018-0848-2
Published:
DOI: https://doi.org/10.1007/s11934-018-0848-2